Center for Coronary Artery Disease
Millions of Americans experience heart attacks each year caused by coronary artery disease. Our goal is to provide every patient with treatment that is long-lasting, low-risk and minimally invasive.
The Center for Coronary Artery Disease is one of seven niche centers within Bluhm Cardiovascular Institute – a nationally recognized health care destination for those requiring highly specialized cardiovascular care.
What is coronary artery disease?
Atherosclerosis, or hardening of the arteries, is a slow process in which deposits of fat, cholesterol and calcium build up inside your arteries (deposits called plaque). This plaque causes your artery walls to become rough, hard and more narrow. When your heart vessels are affected, blood flow and oxygen to your heart are decreased. Atherosclerosis can lead to coronary artery disease (CAD), and when the obstruction reaches a critical point, a heart attack (also known as a myocardial infarction) occurs.
Northwestern Medicine focuses on treating patients before they develop a sometimes fatal heart attack, using advanced treatment options. If you have coronary artery disease that requires coronary angioplasty or bypass surgery, know that Northwestern Medicine consistently ranks among the top hospitals in the nation for exceptional interventional and surgical outcomes.
Meet the Teams
Conditions
Treatments
- Cardiac Behavioral Medicine
- Coronary Artery Bypass Graft Surgery
- High Risk Percutaneous Coronary Intervention (CHIP)
- Lipid (Cholesterol) Management
- Medications for Heart and Vascular Disease
- Percutaneous Coronary Intervention (PCI) Angioplasty and Stenting
- Risk Reduction for Heart and Vascular Disease
Coronary Artery Disease Clinical Trials
Empower This study aims to generate real-world clinical evidence associated with coronary intravascular lithotripsy (IVL) in a population of female subjects with calcified coronary artery disease. Eligible participants will receive Coronary Intravascular Lithotripsy via Shockwave Medical Coronary IVL System. Subjects will have clinical follow-up prior to discharge from the intervention and at 30 days, 1, 2 and 3 years.
Principal Investigator: Ranya Sweis, MD